Zura Bio Limited (ZURA)
NASDAQ: ZURA
· Real-Time Price · USD
1.66
-0.06 (-3.49%)
At close: Aug 15, 2025, 3:59 PM
1.73
4.53%
After-hours: Aug 15, 2025, 07:52 PM EDT
Zura Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | n/a | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 1K | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 1K | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -19.25M | -15.73M | -19.32M | -11.76M | -8.38M | -10.83M | -10.19M | -33.91M | -7.72M | -1.07M | -927K | -412.33K | -514.5K | -321.86K | -19.14K |
Interest Income | -1.82M | 2.13M | 2.46M | 2.2M | 1.22M | 1.37M | 815K | n/a | 1K | n/a | n/a | 16.31K | 12.16K | 6.95K | n/a |
Pretax Income | -17.44M | -13.63M | -20.7M | -10.33M | -7.75M | -8.47M | -8.27M | -34.02M | -9.79M | -1.1M | -925K | 147.86K | 817.63K | 5.79M | -19.14K |
Net Income | -17.44M | -13.63M | -20.7M | -12.67M | -730K | -8.47M | -8.27M | -34.02M | -9.59M | -1.1M | -925K | 147.86K | 817.63K | 5.79M | -19.14K |
Selling & General & Admin | 8.78M | 6.49M | 13.29M | 6.22M | 4.79M | 3.91M | 6.22M | 5.67M | 2.83M | 653K | 842K | 412.33K | 514.5K | 321.86K | 19.14K |
Research & Development | 10.47M | 9.24M | 6.03M | 5.54M | 3.59M | 6.92M | 3.96M | 28.23M | 4.88M | 415K | 85K | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | 2K | 23K | 24K | -4K | n/a | -9K | n/a | 2K | n/a | n/a | n/a | n/a |
Operating Expenses | 19.25M | 15.73M | 19.32M | 11.76M | 8.38M | 10.83M | 10.19M | 33.91M | 7.72M | 1.07M | 927K | 412.33K | 514.5K | 321.86K | 19.14K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 15.73M | 19.32M | 11.76M | 8.38M | 10.83M | 10.19M | 33.91M | 7.72M | 1.07M | 927K | 412.33K | 514.5K | 321.86K | 19.14K |
Income Tax Expense | n/a | n/a | 2.24M | n/a | -8.23M | n/a | n/a | n/a | n/a | 6.92K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 65.3M | 65.3M | 87.34M | 74.95M | 46.91M | 47.05M | 46.88M | 34.3M | 35.52M | 17.25M | 17.25M | 17.25M | 17.25M | 17.25M | 17.25M |
Shares Outstanding (Diluted) | 65.3M | 65.3M | 87.34M | 74.95M | 46.91M | 47.05M | 46.88M | 34.3M | 35.52M | 17.25M | 17.25M | 17.25M | 17.25M | 17.25M | 17.25M |
EPS (Basic) | -0.19 | 0.48 | -0.26 | -0.17 | -0.02 | -0.18 | -0.18 | -0.99 | -0.27 | -0.06 | -0.05 | 0.01 | 0.05 | 0.34 | -0.00 |
EPS (Diluted) | -0.27 | 0.48 | -0.26 | -0.17 | -0.02 | -0.18 | -0.18 | -0.99 | -0.27 | -0.06 | -0.05 | 0.01 | 0.05 | 0.34 | -0.00 |
EBITDA | -19.25M | -15.73M | -19.32M | -11.76M | -8.38M | -10.83M | -10.19M | -33.91M | -7.72M | -1.07M | -927K | 147.86K | 817.63K | 5.79M | -19.14K |
EBIT | n/a | -13.63M | -19.32M | -11.76M | -8.38M | -10.83M | -10.19M | -33.91M | -7.72M | -1.07M | -927K | 147.86K | 817.63K | 5.79M | -19.14K |
Depreciation & Amortization | n/a | 5K | 3K | 1K | 43.28K | 43.81K | -39.59K | 122.08K | 41.58K | 27.08K | 86.06K | n/a | n/a | n/a | n/a |